Zentalis Pharma Says FDA Grants Fast Track Status on Azenosertib Cancer Drug Candidate
In This Article:
Zentalis Pharmaceuticals (ZNTL) said Thursday the US Food and Drug Administration granted fast track
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.